Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652181 · ClinicalTrials.gov registry record
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 123
- Enrollment target
NCT03652181 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 123 participants.
The verdict
NCT03652181 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
Brain Cavernous Angiomas with Symptomatic Hemorrhage (CASH) are rare, but they exact a heavy burden of neurologic disability from recurrent bleeding, for which there is no proven therapy. This trial readiness project aims to address current critical obstacles in identifying cases at multiple sites, characterizing their relevant features, and measuring their outcome. The timing cannot be more opportune, with therapeutic targets already identified, exceptional collaboration among researchers and with the patient community, and several drugs ready to benefit from a track to clinical testing in the next five years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2018-08-20 |
| Est. Completion | 2022-11-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652181
The ClinicalTrials.gov registry entry for NCT03652181 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03652181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03652181 about?
NCT03652181 is a clinical study titled "CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness". Brain Cavernous Angiomas with Symptomatic Hemorrhage (CASH) are rare, but they exact a heavy burden of neurologic disability from recurrent bleeding, for which there is no proven therapy. This trial readiness project aims to address current critical obstacles in identifying cases at multiple sites, ...
What is the current status of trial NCT03652181?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2018-08-20. Estimated completion is 2022-11-03.
Who is sponsoring clinical trial NCT03652181?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.